Cargando…

KRAS-driven miR-29b expression is required for tumor suppressor gene silencing

KRAS activation drives DNA methylation and silencing of specific tumor suppressor genes (TSGs). We previously showed that the ERK pathway induces transcriptional repression of TET1, which results in conversion of TSG promoters from a hydroxymethylated, active state to a hypermethylated and silenced...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thakur, Shilpa, Brenner, Charles
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5650376/ https://www.ncbi.nlm.nih.gov/pubmed/29088821 http://dx.doi.org/10.18632/oncotarget.20364

Ejemplares similares

Is miR-29 an oncogene or tumor suppressor in CLL?
por: Pekarsky, Yuri, et al.
Publicado: (2010)

MiR-22 as a metabolic silencer and liver tumor suppressor
por: Wang, Lijun, et al.
Publicado: (2020)

The Roles of miR-26, miR-29, and miR-203 in the Silencing of the Epigenetic Machinery during Melanocyte Transformation
por: Gasque Schoof, Cláudia Regina, et al.
Publicado: (2015)

miR-29s function as tumor suppressors in gliomas by targeting TRAF4 and predict patient prognosis
por: Shi, Cuijuan, et al.
Publicado: (2018)

The Tumor Suppressor Roles of miR-433 and miR-127 in Gastric Cancer
por: Guo, Li-Hua, et al.
Publicado: (2013)

Tumor-Derived Exosomal miR-29b Reduces Angiogenesis in Pancreatic Cancer by Silencing ROBO1 and SRGAP2
por: Wang, Lihua, et al.
Publicado: (2022)

MALAT1 silencing suppresses prostate cancer progression by upregulating miR-1 and downregulating KRAS
por: Chang, Junkai, et al.
Publicado: (2018)

MiR-29a function as tumor suppressor in cervical cancer by targeting SIRT1 and predict patient prognosis
por: Nan, Ping, et al.
Publicado: (2019)

Altered expression pattern of miR-29a, miR-29b and the target genes in myeloid leukemia
por: Xu, Ling, et al.
Publicado: (2014)

The Tumor Suppressor Role of miR-124 in Osteosarcoma
por: Geng, Shuo, et al.
Publicado: (2014)

The miR-125a and miR-320c are potential tumor suppressor microRNAs epigenetically silenced by the polycomb repressive complex 2 in multiple myeloma
por: Alzrigat, Mohammad, et al.
Publicado: (2017)

Epigenetic Silencing of Tumor Suppressor miR-124 Directly Supports STAT3 Activation in Cutaneous T-Cell Lymphoma
por: García-Colmenero, Lidia, et al.
Publicado: (2020)

miR-450b-5p induced by oncogenic KRAS is required for colorectal cancer progression
por: Ye, Ya-Ping, et al.
Publicado: (2016)

Ezh2 Acts as a Tumor Suppressor in Kras-driven Lung Adenocarcinoma
por: Wang, Yanxiao, et al.
Publicado: (2017)

MiR-29a Function as Tumor Suppressor in Cervical Cancer by Targeting SIRT1 and Predict Patient Prognosis [Retraction]
Publicado: (2023)

Serum levels of miR-29, miR-122, miR-155 and miR-192 are elevated in patients with cholangiocarcinoma
por: Loosen, Sven H., et al.
Publicado: (2019)

Retraction: The Tumor Suppressor Role of miR-124 in Osteosarcoma
por: Geng, Shuo, et al.
Publicado: (2019)

miR-17 acts as a tumor suppressor by negatively regulating the miR-17-92 cluster
por: Sweat, Yan, et al.
Publicado: (2021)

Plasma levels of miR‐29b and miR‐200b in type 2 diabetic retinopathy
por: Dantas da Costa e Silva, Maria Enoia, et al.
Publicado: (2018)

Discovery and functional implications of a miR-29b-1/miR-29a cluster polymorphism in acute myeloid leukemia
por: Ngankeu, Apollinaire, et al.
Publicado: (2017)

The Role of miR-29 Family in TGF-β Driven Fibrosis in Glaucomatous Optic Neuropathy
por: Smyth, Aoife, et al.
Publicado: (2022)

The role of miR‐29 family in disease
por: Horita, Masahiro, et al.
Publicado: (2021)

miR-29a/b/c function as invasion suppressors for gliomas by targeting CDC42 and predict the prognosis of patients
por: Shi, Cuijuan, et al.
Publicado: (2017)

MiR-382 functions as tumor suppressor and chemosensitizer in colorectal cancer
por: Yao, Hui, et al.
Publicado: (2019)

Metformin decreases miR-122, miR-223 and miR-29a in women with polycystic ovary syndrome
por: Udesen, Pernille Bækgaard, et al.
Publicado: (2020)

Association of H-Type Hypertension with miR-21, miR-29, and miR-199 in Kazahks of Xinjiang, China
por: He, Xin, et al.
Publicado: (2022)

Interactive role of miR‐29, miR‐93, miR‐205, and VEGF in salivary adenoid cystic carcinoma
por: Bayat, Parisa, et al.
Publicado: (2022)

Expression of miR-30c and miR-29b in prostate cancer and its diagnostic significance
por: Zhu, Chuanan, et al.
Publicado: (2018)

Uracils at nucleotide position 9–11 are required for the rapid turnover of miR-29 family
por: Zhang, Zhuo, et al.
Publicado: (2011)

Application values of miR-194 and miR-29 in the diagnosis and prognosis of gastric cancer
por: Zhao, Xin, et al.
Publicado: (2018)

EZH2-mediated Epigenetic Silencing of miR-29/miR-30 targets LOXL4 and contributes to Tumorigenesis, Metastasis, and Immune Microenvironment Remodeling in Breast Cancer
por: Yin, Huilong, et al.
Publicado: (2020)

The proto-oncogene KRAS is targeted by miR-200c
por: Kopp, Florian, et al.
Publicado: (2013)

miR-29b, miR-205 and miR-221 Enhance Chemosensitivity to Gemcitabine in HuH28 Human Cholangiocarcinoma Cells
por: Okamoto, Kinya, et al.
Publicado: (2013)

miR-29b and miR-29c Are Involved in Toll-Like Receptor Control of Glucocorticoid-Induced Apoptosis in Human Plasmacytoid Dendritic Cells
por: Hong, Yongfeng, et al.
Publicado: (2013)

Circulating miR-17, miR-20a, miR-29c, and miR-223 Combined as Non-Invasive Biomarkers in Nasopharyngeal Carcinoma
por: Zeng, Xi, et al.
Publicado: (2012)

Diagnostic and prognostic potential of miR-21, miR-29c, miR-148 and miR-203 in adenocarcinoma and squamous cell carcinoma of esophagus
por: Hezova, Renata, et al.
Publicado: (2015)

Tumor Suppressor Function of miR-127-3p and miR-376a-3p in Osteosarcoma Cells
por: Fellenberg, Joerg, et al.
Publicado: (2019)

Circulating Plasma Levels of miR-20b, miR-29b and miR-155 as Predictors of Bevacizumab Efficacy in Patients with Metastatic Colorectal Cancer
por: Ulivi, Paola, et al.
Publicado: (2018)

MiR-29/Hsp47 in ECM network
por: Xu, Ren
Publicado: (2015)

A Systematic Review of miR-29 in Cancer
por: Kwon, Jason J., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_clt2q3096cer6m5esp8pv29906